PTK2B |
PTK2B, FAK2, PYK2, RAFTK: Protein tyrosine kinase 2 beta |
LYN |
LYN: Tyrosine-protein kinase Lyn |
106.000 |
Evidence |
|
VAV1 |
VAV1, VAV: Proto-oncogene vav |
PTK2B |
PTK2B, FAK2, PYK2, RAFTK: Protein tyrosine kinase 2 beta |
106.000 |
Evidence |
|
BTK |
BTK, AGMX1, ATK, BPK: Tyrosine-protein kinase BTK |
ITK |
ITK, EMT, LYK: Tyrosine-protein kinase ITK/TSK |
106.000 |
Evidence |
|
PTK2B |
PTK2B, FAK2, PYK2, RAFTK: Protein tyrosine kinase 2 beta |
JAK1 |
|
106.000 |
Evidence |
|
RASA1 |
RASA1, RASA: Ras GTPase-activating protein 1 |
CSK |
CSK: Tyrosine-protein kinase CSK |
106.000 |
Evidence |
|
POLR2D |
POLR2D: DNA-directed RNA polymerase II subunit RPB4 |
POLR2A |
POLR2A: Uncharacterized protein POLR2A |
106.000 |
Evidence |
O
|
POLR2D |
POLR2D: DNA-directed RNA polymerase II subunit RPB4 |
POLR2B |
POLR2B: DNA-directed RNA polymerase II subunit RPB2 |
106.000 |
Evidence |
O
|
PDHA1 |
PDHA1, PHE1A: Pyruvate dehydrogenase E1 component subunit alpha, somatic form, m |
DLAT |
Dihydrolipoamide S-acetyltransferase (Fragment) |
106.000 |
Evidence |
O
|
EIF2S2 |
EIF2S2, EIF2B: Eukaryotic translation initiation factor 2 subunit 2 |
EIF2B5 |
EIF2B5, EIF2BE: Translation initiation factor eIF-2B subunit epsilon |
105.000 |
Evidence |
O
|
ACTG1 |
ACTB: Actin, cytoplasmic 1 |
CFL1 |
CFL1, CFL: Cofilin-1 |
105.000 |
Evidence |
O
|
JAK2 |
JAK2: Tyrosine-protein kinase JAK2 |
RAF1 |
RAF1, RAF: RAF proto-oncogene serine/threonine-protein kinase |
105.000 |
Evidence |
O
|
CRYAA |
CRYAA, CRYA1, HSPB4: Alpha-crystallin A chain |
CRYBB2 |
CRYBB2, CRYB2, CRYB2A: Beta-crystallin B2 |
105.000 |
Evidence |
O
|
CRYAB |
CRYAB, CRYA2: Alpha-crystallin B chain |
CRYGC |
CRYGC, CRYG3: Gamma-crystallin C |
105.000 |
Evidence |
O
|
ERBB3 |
ERBB3, HER3: Receptor tyrosine-protein kinase erbB-3 precursor |
GRB2 |
GRB2, ASH: Growth factor receptor-bound protein 2 |
104.000 |
Evidence |
|
FLT1 |
FLT1, FLT, FRT: Vascular endothelial growth factor receptor 1 precursor |
GRB2 |
GRB2, ASH: Growth factor receptor-bound protein 2 |
104.000 |
Evidence |
|
RET |
RET: Proto-oncogene tyrosine-protein kinase receptor ret precursor |
GRB2 |
GRB2, ASH: Growth factor receptor-bound protein 2 |
104.000 |
Evidence |
|
STAT2 |
STAT2: Signal transducer and activator of transcription 2 |
JAK1 |
|
102.000 |
Evidence |
|
PRSS1 |
PRSS1, TRP1, TRY1, TRYP1: Trypsin-1 precursor |
SERPINF2 |
SERPINF2, AAP, PLI: Alpha-2-antiplasmin precursor |
102.000 |
Evidence |
O
|
YWHAB |
YWHAB: 14-3-3 protein beta/alpha |
PARD6B |
PARD6B, PAR6B: Partitioning defective 6 homolog beta |
101.000 |
Evidence |
|
NBN |
NBN, NBS, NBS1, P95: Nibrin |
ATR |
ATR, FRP1: Serine/threonine-protein kinase ATR |
101.000 |
Evidence |
|
HLA-B |
HLA-B, HLAB: HLA class I histocompatibility antigen, B-7 alpha chain precursor |
LILRB1 |
IPI00385703 |
101.000 |
Evidence |
|
CBL |
CBL, CBL2, RNF55: E3 ubiquitin-protein ligase CBL |
LCK |
LCK: Proto-oncogene tyrosine-protein kinase LCK |
101.000 |
Evidence |
O
|
INSR |
INSR: Insulin receptor precursor |
SRC |
SRC, SRC1: Proto-oncogene tyrosine-protein kinase Src |
101.000 |
Evidence |
|
ABL1 |
ABL1, ABL, JTK7: Proto-oncogene tyrosine-protein kinase ABL1 |
EPHB2 |
EPHB2, DRT, EPHT3, EPTH3, ERK, HEK5, TYRO5: Ephrin type-B receptor 2 precursor |
101.000 |
Evidence |
|
SOCS3 |
SOCS3, CIS3, SSI3: Suppressor of cytokine signaling 3 |
INSR |
INSR: Insulin receptor precursor |
101.000 |
Evidence |
|